Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen M Shannon

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Handbook of Clinical Neurology|April 19, 2011
Huntington's disease - clinical signs, symptoms, presymptomatic diagnosis, and diagnosisKathleen M Shannon
Nature Clinical Practice. Neurology|October 15, 2008
Long-term outcome in Parkinson disease: no advantage to initiating therapy with dopamine agonistsKathleen M Shannon
Frontiers in Neurology|April 15, 2022
Gut-Derived Sterile Inflammation and Parkinson's DiseaseKathleen M Shannon
Journal of Parkinson'S Disease|June 20, 2022
Infections and Changes in Commensal Bacteria and the Pathogenesis of Parkinson's DiseaseKathleen M Shannon
Neurology|July 25, 2007
Dopamine: so "last century"Kathleen M Shannon
Expert Opinion on Investigational Drugs|February 17, 2016
Pridopidine for the treatment of Huntington's diseaseKathleen M Shannon
Current Treatment Options in Neurology|April 9, 2005
HemiballismusKathleen M Shannon
CNS Drugs|January 15, 2020
Recent Advances in the Treatment of Huntington's Disease: Targeting DNA and RNAKathleen M Shannon
Movement Disorders : Official Journal of the Movement Disorder Society|August 1, 2015
Therapeutic advances in Huntington's DiseaseKathleen M Shannon, Avram Fraint
Movement Disorders : Official Journal of the Movement Disorder Society|April 23, 2014
Gut feelings about smoking and coffee in Parkinson's diseasePascal Derkinderen, Kathleen M Shannon, Patrik Brundin
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Handbook of Clinical Neurology|April 19, 2011
Huntington's disease - clinical signs, symptoms, presymptomatic diagnosis, and diagnosisKathleen M Shannon
Nature Clinical Practice. Neurology|October 15, 2008
Long-term outcome in Parkinson disease: no advantage to initiating therapy with dopamine agonistsKathleen M Shannon
Frontiers in Neurology|April 15, 2022
Gut-Derived Sterile Inflammation and Parkinson's DiseaseKathleen M Shannon
Journal of Parkinson'S Disease|June 20, 2022
Infections and Changes in Commensal Bacteria and the Pathogenesis of Parkinson's DiseaseKathleen M Shannon
Neurology|July 25, 2007
Dopamine: so "last century"Kathleen M Shannon
Expert Opinion on Investigational Drugs|February 17, 2016
Pridopidine for the treatment of Huntington's diseaseKathleen M Shannon
Current Treatment Options in Neurology|April 9, 2005
HemiballismusKathleen M Shannon
CNS Drugs|January 15, 2020
Recent Advances in the Treatment of Huntington's Disease: Targeting DNA and RNAKathleen M Shannon
Movement Disorders : Official Journal of the Movement Disorder Society|August 1, 2015
Therapeutic advances in Huntington's DiseaseKathleen M Shannon, Avram Fraint
Movement Disorders : Official Journal of the Movement Disorder Society|April 23, 2014
Gut feelings about smoking and coffee in Parkinson's diseasePascal Derkinderen, Kathleen M Shannon, Patrik Brundin
Pageof 4